
### [MONDO:0019256](http://purl.obolibrary.org/obo/MONDO_0019256)
**Label:** sterol metabolism disorder

**Subclasses:** [MONDO:0019218](http://purl.obolibrary.org/obo/MONDO_0019218) (disorder of bile acid synthesis), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0015581](http://purl.obolibrary.org/obo/MONDO_0015581) (bile acid synthesis defect with cholestasis and malabsorption), [MONDO:0017708](http://purl.obolibrary.org/obo/MONDO_0017708) (mevalonate kinase deficiency), [MONDO:0019240](http://purl.obolibrary.org/obo/MONDO_0019240) (sterol biosynthesis disorder), [MONDO:0010556](http://purl.obolibrary.org/obo/MONDO_0010556) (X-linked chondrodysplasia punctata), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), 

**Corr. equiv. classes:** [Orphanet:163631](http://www.orpha.net/ORDO/Orphanet_163631), [Orphanet:35173](http://www.orpha.net/ORDO/Orphanet_35173), [OMIM:302960](http://purl.obolibrary.org/obo/OMIM_302960), [Orphanet:485631](http://www.orpha.net/ORDO/Orphanet_485631), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [Orphanet:79195](http://www.orpha.net/ORDO/Orphanet_79195), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), [Orphanet:309025](http://www.orpha.net/ORDO/Orphanet_309025), [Orphanet:79168](http://www.orpha.net/ORDO/Orphanet_79168), 

**Class expressions from DL-Learner:**

- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0002570](http://purl.obolibrary.org/obo/HP_0002570) (Steatorrhea))) 66.67%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and [HP:0004297](http://purl.obolibrary.org/obo/HP_0004297) (Abnormality of the biliary system) 59.97%
- [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 59.97%
- [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 55.40%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology))) 55.40%
- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0011106](http://purl.obolibrary.org/obo/HP_0011106) (Hypovolemia))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0011104](http://purl.obolibrary.org/obo/HP_0011104) (Abnormality of blood volume homeostasis))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0010512](http://purl.obolibrary.org/obo/HP_0010512) (Adrenal calcification))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0004333](http://purl.obolibrary.org/obo/HP_0004333) (Bone-marrow foam cells))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0003124](http://purl.obolibrary.org/obo/HP_0003124) (Hypercholesterolemia))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0002092](http://purl.obolibrary.org/obo/HP_0002092) (Pulmonary arterial hypertension))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0002040](http://purl.obolibrary.org/obo/HP_0002040) (Esophageal varix))) 52.02%
- [HP:0002630](http://purl.obolibrary.org/obo/HP_0002630) (Fat malabsorption) and (not ([HP:0001922](http://purl.obolibrary.org/obo/HP_0001922) (Vacuolated lymphocytes))) 52.02%


